Integra Lifesciences Holdings Corp (IART) 8-K Report: Key Updates & Insights

$IART
8-K
Filed on: 2025-01-06
View Source
Integra Lifesciences Holdings Corp (IART) 8-K Report: Key Updates & Insights

Here are the key insights extracted from the provided section of the financial report:

  1. Entity Information:
  • Company Name: Integra Lifesciences Holdings Corp (IART)
  • Location: 1100 Campus Road, Princeton, NJ 08540
  • Contact Number: 609-275-0500
  • SEC CIK Number: 0000917520
  • SEC File Number: 0-26224
  • EIN: 51-0317849
  1. Filing Details:
  • Filing Type: 8-K (a report of unscheduled material events or corporate changes)
  • Filing Date: December 19, 2024
  1. Stock Information:
  • Common Stock: Par value of $0.01 per share
  • Stock Exchange Listing: NASDAQ
  • Ticker Symbol: IART
  1. Reporting Period:
  • Start Date: December 19, 2024
  • End Date: December 19, 2024
  1. XBRL Details:
  • The document is structured in XBRL format, which is an XML-based format for the electronic communication of business and financial data.

This information indicates that the company is reporting a material event or update as required by the SEC, and it is relevant for investors and analysts monitoring developments concerning Integra Lifesciences Holdings Corp.

You May Also Like